[go: up one dir, main page]

AU2001241875A1 - Human dynamin 40322 - Google Patents

Human dynamin 40322

Info

Publication number
AU2001241875A1
AU2001241875A1 AU2001241875A AU4187501A AU2001241875A1 AU 2001241875 A1 AU2001241875 A1 AU 2001241875A1 AU 2001241875 A AU2001241875 A AU 2001241875A AU 4187501 A AU4187501 A AU 4187501A AU 2001241875 A1 AU2001241875 A1 AU 2001241875A1
Authority
AU
Australia
Prior art keywords
human dynamin
dynamin
human
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001241875A
Inventor
Rachel A Meyers
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Millennium Pharmaceuticals Inc
Original Assignee
Millennium Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Millennium Pharmaceuticals Inc filed Critical Millennium Pharmaceuticals Inc
Publication of AU2001241875A1 publication Critical patent/AU2001241875A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4722—G-proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU2001241875A 2000-02-28 2001-02-28 Human dynamin 40322 Abandoned AU2001241875A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US18550300P 2000-02-28 2000-02-28
US60/185,503 2000-02-28
PCT/US2001/006511 WO2001064880A2 (en) 2000-02-28 2001-02-28 Human dynamin 40322

Publications (1)

Publication Number Publication Date
AU2001241875A1 true AU2001241875A1 (en) 2001-09-12

Family

ID=22681250

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001241875A Abandoned AU2001241875A1 (en) 2000-02-28 2001-02-28 Human dynamin 40322

Country Status (3)

Country Link
US (1) US20020076784A1 (en)
AU (1) AU2001241875A1 (en)
WO (1) WO2001064880A2 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050176659A1 (en) * 2001-11-08 2005-08-11 Bettina Rudolph Endophilin homologous proteins involved in the regulation of energy homeostasis
WO2005049009A1 (en) * 2003-11-21 2005-06-02 The University Of Newcastle Research Associates Limited Methods and agents for inhibiting dynamin-dependent endocytosis
KR100565732B1 (en) * 2004-02-26 2006-03-28 씨제이 주식회사 Gammabutylopetine hydroxylase of Neurospora Krasa origin
US9144594B2 (en) 2005-11-08 2015-09-29 University Of Miami Cathepsin L mediated diseases and associated methods and products
WO2007056435A2 (en) * 2005-11-08 2007-05-18 The General Hospital Corporation Dynamin mediated diseases and associated methods and products
US20080306007A1 (en) * 2007-04-30 2008-12-11 Newcastle Innovation Limited Agents for prophylaxis or treatment of neurological related diseases and conditions
US8809386B2 (en) 2009-05-21 2014-08-19 Children's Medical Research Institute Use of dynamin ring stabilizers
KR102162847B1 (en) 2019-01-23 2020-10-07 차의과학대학교 산학협력단 Analytical method for diagnosing urolithiasis and kit therefor

Also Published As

Publication number Publication date
US20020076784A1 (en) 2002-06-20
WO2001064880A2 (en) 2001-09-07
WO2001064880A9 (en) 2003-01-16
WO2001064880A3 (en) 2002-01-03

Similar Documents

Publication Publication Date Title
AU2001259702A1 (en) Tissue regrafting
AUPR814401A0 (en) Human 3 relaxin
AU2001268750A1 (en) Flushed-seal respirator
AU2002224553A1 (en) Human proteases
AU2002210916A1 (en) Endoscope attachment and endoscope
AU2001272974A1 (en) Human receptors
AU2001227833A1 (en) 71 human secreted proteins
AU2002227925A1 (en) Human beta-defensin-3
AU2001241875A1 (en) Human dynamin 40322
AU2501200A (en) Human peptidases
AU4432001A (en) Trityl-type compounds and their use
AUPR069500A0 (en) Tissue modification
AU2227999A (en) Human ependymin
AU2001229507A1 (en) 21 human secreted proteins
AU2002219846A1 (en) Novel use
AU2001243447A1 (en) 16835, a human phospholipase c and uses thereof
AU2001277519A1 (en) Bio-probes and use thereof
AU2001229503A1 (en) 17 human secreted proteins
GB2358857B (en) Coffins
AU2202100A (en) Human brainiac-5
AU2001229563A1 (en) 21 human secreted proteins
AU2001281116A1 (en) Human serpin zserp15
AU6042601A (en) Compounds and their uses
AU2001283321A1 (en) A human phospholipase c and uses thereof
AU2001230942A1 (en) 7 human secreted proteins